ACTH Receptor (MC2R) Specificity: What Do We Know About Underlying Molecular Mechanisms?

Area of Science:

• Endocrinology
• Molecular Pharmacology
• Receptor Biology

Background:

• The adrenocorticotropic hormone receptor (ACTHR), or melanocortin type 2 receptor (MC2R), is one of five mammalian melanocortin receptors (MCRs).
• All MCRs bind melanocortins (MCs) derived from proopiomelanocortin, sharing a common pharmacophore, but ACTHR uniquely binds only adrenocorticotropic hormone (ACTH).
• Functional studies of ACTHR have lagged due to expression challenges, with the receptor being retained in the endoplasmic reticulum in non-endogenous cell lines.

Purpose of the Study:

• To review advances in understanding the molecular mechanisms of ACTHR action.
• To summarize the research progress in the field of ACTHR, 25 years after its discovery.

Main Methods:

• Review of published literature on ACTHR and other MCRs.
• Discussion of methodological challenges and breakthroughs in ACTHR research.
• Highlighting the discovery of melanocortin receptor accessory protein (MRAP) and its role.

Main Results:

• ACTHR expression and function require specific cell lines or the presence of MRAP.
• The discovery of MRAP in 2005 resolved major methodological hurdles in ACTHR research.
• Significant insights into ACTHR's molecular mechanisms have been gained in the decade following the MRAP discovery.

Conclusions:

• The identification of MRAP was crucial for overcoming expression and functional study limitations of ACTHR.
• Recent research has significantly advanced our understanding of ACTHR's molecular actions.
• ACTHR remains a unique and attractive target for molecular pharmacology research.